Emily Kopp, Web Producer at Kaiser Health News, most recently worked as a freelance reporter. She has previously worked at Politico and AIS Health. Before that, she interned with the Center for Responsive Politics.
Emily Kopp
From this contributor
Nonprofit with ties to pharma launches campaign against drug imports
Both the Pharmaceutical Research and Manufacturers of America and the nonprofit group have gone to great lengths to show that drugmakers are not driving what they describe as a “grass-roots” effort to fight imports.
Nonprofit with ties to pharma launches campaign against drug imports
By
Emily Kopp, Rachel Bluth, Kaiser Health News
20 April 2017 | 8 min read
Senators want answers about reported probe of U.S. health secretary
Nine U.S. senators are pushing the U.S. Attorney General to reveal what he knows about a reported investigation into Tom Price’s stock trades that a top federal prosecutor might have begun before being fired by the Trump administration.
Senators want answers about reported probe of U.S. health secretary
By
Emily Kopp, Rachel Bluth, Kaiser Health News
31 March 2017 | 4 min read
Most patient advocacy groups accept funding from pharma
At least 83 percent of the United States' largest patient advocacy groups take contributions from the drug industry, and not all of them are transparent about it.
Most patient advocacy groups accept funding from pharma
By
Emily Kopp, Kaiser Health News
2 March 2017 | 5 min read
Explore more from The Transmitter
The last two-author neuroscience paper?
Author lists on papers have ballooned, and it’s getting hard to discern contribution.
The last two-author neuroscience paper?
Author lists on papers have ballooned, and it’s getting hard to discern contribution.
By
Lydia Denworth
25 February 2025 | 3 min read
Attention and IQ link; AUTS2-related syndrome; Glyx-13 for fragile X
Here is a roundup of autism-related news and research spotted around the web for the week of 24 February.
Attention and IQ link; AUTS2-related syndrome; Glyx-13 for fragile X
Here is a roundup of autism-related news and research spotted around the web for the week of 24 February.
By
Jill Adams
25 February 2025 | 1 min read
Adapt or die: Safeguarding the future of diversity and inclusion funding in neuroscience
As diversity and inclusion funding initiatives crumble, we as neuroscientists need to change how we write grants, better communicate the economic benefits of our work and engage in constructive conflict when necessary.
Adapt or die: Safeguarding the future of diversity and inclusion funding in neuroscience
As diversity and inclusion funding initiatives crumble, we as neuroscientists need to change how we write grants, better communicate the economic benefits of our work and engage in constructive conflict when necessary.
By
David Barker
25 February 2025 | 6 min read